Biotech & Medicine
53 articles RSS
FDA Approves First Wearable Electric-Field Device for Pancreatic Cancer, the Disease's First New Treatment in Nearly Three Decades
Novocure's Optune Pax uses tumor treating fields to extend survival by two months in locally advanced pancreatic cancer, earning FDA approval through its most rigorous pathway.
Scientists Pinpoint the Brain Network Behind Parkinson's Disease and Show All Major Therapies Converge on It
An 863-person Nature study identifies the SCAN brain network as the core driver of Parkinson's, with all four major treatments working by reducing its abnormal hyperconnectivity.
The FDA's Plausible Mechanism Pathway: How Baby KJ's Personalized CRISPR Therapy Is Rewriting the Rules of Drug Approval
The FDA's new Plausible Mechanism Pathway enables approval of one-patient gene editing therapies without traditional clinical trials, inspired by the first personalized CRISPR cure for an infant with a fatal metabolic disorder — but ethicists warn of a regulatory Pandora's box.
Moderna-Merck Personalized mRNA Cancer Vaccine Sustains 49% Melanoma Risk Reduction at Five Years
Five-year KEYNOTE-942 trial data show Moderna and Merck's individualized neoantigen mRNA vaccine maintains a 49% reduction in melanoma recurrence or death.
Epigenetic CRISPR Technique Reactivates Silenced Genes Without Cutting DNA
UNSW and St. Jude researchers demonstrate that removing methyl tags from DNA can switch genes back on, opening safer paths for treating sickle cell disease.